Andrew S Feigin

Summary

Publications

  1. ncbi Advances in Huntington's disease: implications for experimental therapeutics
    A Feigin
    Movement Disorders Center, Manhassel, NY 11030, USA
    Curr Opin Neurol 11:357-62. 1998
  2. pmc Evidence from biomarkers and surrogate endpoints
    Andrew Feigin
    Center for Neurosciences, North Shore Long Island Jewish Research Institute, Manhasset, New York 11030, USA
    NeuroRx 1:323-30. 2004
  3. ncbi Effects of levodopa on motor sequence learning in Parkinson's disease
    A Feigin
    Center for Neurosciences, North Shore Long Island Jewish Research Institute, Manhasset, NY 11030, USA
    Neurology 60:1744-9. 2003
  4. ncbi Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism
    Andrew Feigin
    Center for Neuroscience, North Shore University Hospital, Manhasset, New York and New York University School of Medicine, New York, New York, USA
    Mov Disord 17:1265-70. 2002
  5. ncbi Recent advances in Huntington's disease: implications for experimental therapeutics
    Andrew Feigin
    Movement Disorders Center and Center for Neurosciences, North Shore Long Island Jewish Research Institute, 444 Community Drive, Manhasset, NY 11030, USA
    Curr Opin Neurol 15:483-9. 2002
  6. ncbi Effects of levodopa infusion on motor activation responses in Parkinson's disease
    A Feigin
    Center for Neurosciences, North Shore LIJ Research Institute, Manhasset, NY 11030, USA
    Neurology 59:220-6. 2002
  7. ncbi Metabolic correlates of levodopa response in Parkinson's disease
    A Feigin
    Center for Neuroscience Research, North Shore University Hospital, Manhasset, NY 11030, USA
    Neurology 57:2083-8. 2001
  8. ncbi FDG PET in the differential diagnosis of parkinsonian disorders
    Thomas Eckert
    Center for Neurosciences, Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY 11030, USA
    Neuroimage 26:912-21. 2005
  9. ncbi L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease
    M Felice Ghilardi
    Department of Physiology and Pharmacology, CUNY Medical School at City College, City University of New York, 138th Street and Convent Avenue, New York, NY 10031, USA
    Parkinsonism Relat Disord 13:146-51. 2007
  10. ncbi Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease
    Dennis J Zgaljardic
    Transitional Learning Center at Galveston, Galveston, TX 77550, USA
    Cogn Behav Neurol 20:184-92. 2007

Research Grants

  1. The Long Island Parkinson's Disease Center
    Andrew Feigin; Fiscal Year: 2007
  2. IMAGING MARKERS FOR ASSESSING PROGRESSION IN MOVEMENT
    Andrew Feigin; Fiscal Year: 2003

Detail Information

Publications10

  1. ncbi Advances in Huntington's disease: implications for experimental therapeutics
    A Feigin
    Movement Disorders Center, Manhassel, NY 11030, USA
    Curr Opin Neurol 11:357-62. 1998
    ..These observations have suggested new therapeutic strategies, and have lent further support for experimental therapeutics aimed at improving mitochondrial function and reducing excitotoxic injury...
  2. pmc Evidence from biomarkers and surrogate endpoints
    Andrew Feigin
    Center for Neurosciences, North Shore Long Island Jewish Research Institute, Manhasset, New York 11030, USA
    NeuroRx 1:323-30. 2004
    ..Furthermore, the evidence required for the development of an SE and the nature of the evidence that can be derived from the use of BMs and SEs will be discussed...
  3. ncbi Effects of levodopa on motor sequence learning in Parkinson's disease
    A Feigin
    Center for Neurosciences, North Shore Long Island Jewish Research Institute, Manhasset, NY 11030, USA
    Neurology 60:1744-9. 2003
    ..Dopaminergic therapy with levodopa improves motor function in PD patients, but the effects of levodopa on cognition in PD remain uncertain...
  4. ncbi Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism
    Andrew Feigin
    Center for Neuroscience, North Shore University Hospital, Manhasset, New York and New York University School of Medicine, New York, New York, USA
    Mov Disord 17:1265-70. 2002
    ..Because of significant individual subject overlap between groups, however, the clinical utility of this method in the differential diagnosis of Parkinsonism remains uncertain...
  5. ncbi Recent advances in Huntington's disease: implications for experimental therapeutics
    Andrew Feigin
    Movement Disorders Center and Center for Neurosciences, North Shore Long Island Jewish Research Institute, 444 Community Drive, Manhasset, NY 11030, USA
    Curr Opin Neurol 15:483-9. 2002
    ....
  6. ncbi Effects of levodopa infusion on motor activation responses in Parkinson's disease
    A Feigin
    Center for Neurosciences, North Shore LIJ Research Institute, Manhasset, NY 11030, USA
    Neurology 59:220-6. 2002
    ..In this study, the authors used PET to assess the effects of levodopa on motor activation responses and determined how these changes related to on-line recordings of movement speed and accuracy...
  7. ncbi Metabolic correlates of levodopa response in Parkinson's disease
    A Feigin
    Center for Neuroscience Research, North Shore University Hospital, Manhasset, NY 11030, USA
    Neurology 57:2083-8. 2001
    ..To assess the effects of levodopa on resting-state brain metabolism in PD...
  8. ncbi FDG PET in the differential diagnosis of parkinsonian disorders
    Thomas Eckert
    Center for Neurosciences, Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY 11030, USA
    Neuroimage 26:912-21. 2005
    ..Computer-assisted methodologies may be particularly helpful in situations where experienced readers of FDG PET images are not readily available...
  9. ncbi L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease
    M Felice Ghilardi
    Department of Physiology and Pharmacology, CUNY Medical School at City College, City University of New York, 138th Street and Convent Avenue, New York, NY 10031, USA
    Parkinsonism Relat Disord 13:146-51. 2007
    ..Motor performance was assessed with simple motor tasks. L-Dopa improved motor scores and movement speed, but had no beneficial effect on either type of sequence learning...
  10. ncbi Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease
    Dennis J Zgaljardic
    Transitional Learning Center at Galveston, Galveston, TX 77550, USA
    Cogn Behav Neurol 20:184-92. 2007
    ..The prevalence of apathy was assessed across select cognitive and psychiatric variables in 32 nondemented patients with Parkinson disease (PD) and 29 demographically matched healthy control participants...

Research Grants4

  1. The Long Island Parkinson's Disease Center
    Andrew Feigin; Fiscal Year: 2007
    ..abstract_text> ..
  2. IMAGING MARKERS FOR ASSESSING PROGRESSION IN MOVEMENT
    Andrew Feigin; Fiscal Year: 2003
    ..The extension of this career development award will allow the candidate to become a fully independent and productive clinical scientist. ..